GingiCaine Gel, Pina Colada

Product NDC: 10129-033
11-digit product format: 101290033
Labeler code: 10129
Product ID: 10129-033_556c6a5b-f738-8d09-e063-6294a90af0b9
Type: HUMAN OTC DRUG
Nonproprietary name: GingiCaine Gel, Pina Colada Flavor
Dosage form: GEL
Route: DENTAL; ORAL; PERIODONTAL
Labeler: Gingi-Pak a Division of the Belport
Application: M022
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 1993-07-06
Substance: BENZOCAINE
Active strength: 200 mg/1
Pharmacologic classes: Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 27 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	10129-033-01	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	10129-033-05	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	10129-033-01	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	10129-033-05	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	10129-033-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	10129-033-05	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	10129-033-01	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	10129-033-05	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	10129-033-01	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	10129-033-05	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	10129-033-01	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	10129-033-05	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	10129-033-05	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	10129-033-01	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	10129-033-05	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	10129-033-01	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	10129-033-05	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	10129-033-01	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: GingiCaine Gel, Pina Colada
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
BENZOCAINE	200 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
U3RSY48JW5	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
238910	Internal RxNorm lookup
543801	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6284e1fe-be33-69bf-e053-2991aa0a90ab	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
d723478e-ad4a-ec23-6bd7-cfe33e1e3840	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
10129-033-01	2025-01-30	GingiCaine Gel, Pina Colada
10129-033-01	2025-01-30	GingiCaine Gel, Pina Colada
10129-033-05	2025-01-30	GingiCaine Gel, Pina Colada
10129-033-05	2025-01-30	GingiCaine Gel, Pina Colada
10129-033-01	2021-09-02	GingiCaine Gel, Pina Colada
10129-033-01	2021-09-02	GingiCaine Gel, Pina Colada
10129-033-05	2021-09-02	GingiCaine Gel, Pina Colada
10129-033-05	2021-09-02	GingiCaine Gel, Pina Colada
10129-033-01	2021-07-23	GingiCaine Gel, Pina Colada
10129-033-01	2021-07-23	GingiCaine Gel, Pina Colada
10129-033-05	2021-07-23	GingiCaine Gel, Pina Colada
10129-033-05	2021-07-23	GingiCaine Gel, Pina Colada

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
10129-033-01	GingiCaine Gel, Pina Colada	1 in 1 BOTTLE, PLASTIC	GEL	1		2
10129-033-05	GingiCaine Gel, Pina Colada	6 in 1 BOTTLE, PLASTIC	GEL	6		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
10129-033	GINGICAINE GEL, PINA COLADA (GINGICAINE GEL, PINA COLADA FLAVOR) GEL [GINGI-PAK A DIVISION OF THE BELPORT]	2	Current NDC, Legacy NDC, 2 package rows	20211210_6284e1fe-be33-69bf-e053-2991aa0a90ab.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 41 · 818 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
GingiCaine Gel, Pina Colada	GINGICAINE GEL, PINA COLADA FLAVOR	Gingi-Pak a Division of the Belport	6284e1fe-be33-69bf-e053-2991aa0a90ab	2026-06-29	Warnings	Exact identifier application number: M022 ndc (product): 10129-033
GingiCaine Gel, Chocolate Mint	GINGICAINE GEL, CHOCOLATE MINT FLAVOR	Gingi-Pak a Division of the Belport	6285c4f2-c139-49a9-e053-2991aa0a2b03	2026-06-29	Warnings	Exact identifier application number: M022
UltraCare Anesthetic Gel	BENZOCAINE	The Bellport Company, Inc. dba Gingi-Pak	f5dd8fa8-0b6a-5a30-e053-2995a90ad194	2026-06-26	Warnings	Exact identifier application number: M022
GingiCaine Gel	GINGICAINE GEL BANANA FLAVOR	Gingi-Pak a Division of the Belport	62857d06-a829-4efa-e053-2991aa0a6d15	2026-06-25	Warnings	Exact identifier application number: M022
GingiCaine Gel, Cotton Candy Flavor	GINGICAINE GEL, COTTON CANDY FLAVOR	Gingi-Pak a Division of the Belport	628515a5-175f-ac2c-e053-2991aa0a19ce	2026-06-25	Warnings	Exact identifier application number: M022
Perox-A-Mint Solution	HYDROGEN PEROXIDE	Sage Products, LLC	50823ff5-ad08-4449-bc4a-9a8ae25ec0d5	2026-06-24	Warnings	Exact identifier application number: M022
Antiseptic Oral Rinse	CETYLPYRIDINIUM CHLORIDE	Sage Products LLC	efff8bae-154d-46bc-8dd4-716800425663	2026-06-24		Exact identifier application number: M022
Anbesol Maximum Strength	BENZOCAINE	Foundation Consumer Brands	8c6ac499-9bd2-4ea5-9f26-df7947bff4a6	2026-06-22	Warnings	Exact identifier application number: M022
Anbesol Maximum Strength	BENZOCAINE	Foundation Consumer Brands	dcc37403-0192-4658-bb7a-059273ce0047	2026-06-22	Warnings	Exact identifier application number: M022
Toothache	POLYHEXAMETHYLENE BIGUANIDE HYDROCHLORIDE	Guchutang Biotechnology (Longyan) Co., Ltd	54ad2ceb-272f-e5ba-e063-6394a90aec5f	2026-06-20	Warnings	Exact identifier application number: M022
Hydrogen Peroxide	HYDROGEN PEROXIDE	Delon Laboratories (1990) Ltd	d4aa09bf-8207-47dd-bc42-01e660da9438	2026-06-16	Warnings	Exact identifier application number: M022
TideFresh MOUTH SORE AND TOOTHACHE	BENZOCAINE 20% MOUTH SORE AND TOOTHACHE	Wenzhou Yuyuan Pharmaceutical Co., Ltd.	541e1814-c00e-efdf-e063-6394a90a41a1	2026-06-13	Warnings	Exact identifier application number: M022
Chloraseptic Sore Throat Max	PHENOL AND GLYCERIN	Prestige Brands Holdings, Inc.	882c940c-b3c3-4aa4-8d64-e4260f066ff4	2026-06-08	Warnings	Exact identifier application number: M022
Orazen	SODIUM MONOFLUOROPHOSPHATE	Orazen Inc	fa5b6bd8-443f-79e7-e053-6394a90a5513	2026-06-03	Warnings	Exact identifier application number: M022
Fishermans Friend Mixed Berry	MENTHOL	Lofthouse of Fleetwood	53391c4d-ee2d-ade3-e063-6394a90ac77d	2026-06-01	Warnings	Exact identifier application number: M022
Orajel Medicated for Toothache and Gum, Liquid	BENZOCAINE AND MENTHOL	Church & Dwight Co., Inc.	ac3d605d-241d-1a6f-e053-2a95a90ae391	2026-06-01	Warnings	Exact identifier application number: M022
MUCINEX INSTASOOTHE SORE THROAT PLUS PAIN RELIEF	BENZOCAINE AND MENTHOL, UNSPECIFIED FORM	Reckitt Benckiser LLC	6140d487-d87c-4954-9247-83492bcc5738	2026-05-27	Warnings	Exact identifier application number: M022
Dolodent Maximum Strength	BENZOCAINE	Pharmadel LLC	351ecc2b-cc1a-2bbf-e063-6394a90a5c14	2026-05-26	Warnings	Exact identifier application number: M022
MOUTH ULCER	PANTHENOL	Guangzhou Shengli Shidai Cosmetics Co., Ltd.	5264f81c-bffe-4f6d-e063-6394a90ae3bf	2026-05-22	Warnings	Exact identifier application number: M022
Sensitivity Relief Fluoride Free	POTASSIUM NITRATE	Health and Natural Beauty USA Corp	c23b2a83-ebc3-4bcf-a216-7693944dcfa0	2026-05-22	Warnings	Exact identifier application number: M022

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
U3RSY48JW5	BENZOCAINE	94-09-7	BENZOCAINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
238910	benzocaine 20 % Oral Gel	PSN	6284e1fe-be33-69bf-e053-2991aa0a90ab	2
543801	Gingicaine 20 % Oral Gel	PSN	6284e1fe-be33-69bf-e053-2991aa0a90ab	2
543801	benzocaine 0.2 MG/MG Oral Gel [Gingicaine]	SBD	6284e1fe-be33-69bf-e053-2991aa0a90ab	2
238910	benzocaine 0.2 MG/MG Oral Gel	SCD	6284e1fe-be33-69bf-e053-2991aa0a90ab	2
238910	benzocaine 20 % (180-220 MG per 1 GM) Oral Gel	SY	6284e1fe-be33-69bf-e053-2991aa0a90ab	2
543801	Gingicaine 0.2 MG/MG Oral Gel	SY	6284e1fe-be33-69bf-e053-2991aa0a90ab	2
543801	Gingicaine 20 % Oral Gel	SY	6284e1fe-be33-69bf-e053-2991aa0a90ab	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
10129-033-01	10129003301	1 GEL in 1 BOTTLE, PLASTIC (10129-033-01)	1 gel	1993-07-06	0000-00-00	No	No	Current
10129-033-05	10129003305	6 GEL in 1 BOTTLE, PLASTIC (10129-033-05)	6 gel	1993-07-06	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
GingiCaine Gel, Pina Colada	Gingi-Pak a Division of the Belport	2026-06-29	HUMAN OTC DRUG LABEL	3